Low-frequency Repetitive Nerve Stimulation in Myotonic Dystrophy Type 1

Status Completed

Clinical Trial Summary

The study design is a prospective cohort study. It aims to evaluate the neuromuscular junction in dystrophic myotonia 1 (DM 1) using low-frequency repetitive nerve stimulation (RNS) on several nerve-muscle pairs of the one side including proximal and distal muscles of upper and lower extremities. First, it will be investigated whether a decrement with 3 Hz stimulation, as described in literature, is reproducible in our patient population. If this is the case, it will be examined whether it is the consequence of a dysfunction of the neuromuscular junction or rather linked to a hypo-excitability of some muscle fibers due to myotonia. For this purpose, additional tests including short exercise test (to observe any decrement resulting from an inexcitability in myotonic muscle fibers) and needle EMG (for mapping myotonic discharges in the muscles tested with repetitive nerve stimulation) will be performed. Single fiber-EMG will not be provided in this study as an abnormal result does not necessarily indicate a dysfunction of the neuromuscular junction but could just as well be due to the muscular dystrophy in the context of DM1. Finally, it will be investigated if there is a correlation between the decrement with 3 Hz stimulation and clinical signs as fixed muscle weakness (via Medical Research Counsil (MRC) scale, DM-activ scale [30]) and fatigue (via MG-ADL scale).

Clinical Trial Description

n/a

Study Design

Related Conditions & MeSH terms

Clinical Trial Details

NCT number	NCT05662150
Study type	Interventional
Source	Vrije Universiteit Brussel
Contact
Status	Completed
Phase	N/A
Start date	September 1, 2021
Completion date	June 20, 2022

View Details

See also
Status	Clinical Trial	Phase
Recruiting	`NCT02880735` - Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy	N/A
Recruiting	`NCT06378216` - Myotonic Dystrophy Type 1 Congenital and Juvenile Form: From Diagnosis to Rehabilitation [MDCJ-NeuBeRe]
Active, not recruiting	`NCT06089018` - Observational Study of Digital Biomarkers of Myotonia and Gait in Adults and Children With Myotonic Dystrophy
Active, not recruiting	`NCT04698551` - NIPD on cffDNA for Triplet Repeat Diseases
Completed	`NCT05027269` - Study of AOC 1001 in Adult Myotonic Dystrophy Type 1 (DM1) Patients	Phase 1/Phase 2
Completed	`NCT04712422` - Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1
Recruiting	`NCT05006924` - Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1
Recruiting	`NCT04656210` - Myotonic Dystrophy - Vascular and Cognition
Completed	`NCT04634682` - Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1	N/A
Withdrawn	`NCT06270186` - Evaluation of Cognitive Functions in 20 Patients With Type 1 Myotonic Dystrophy With Virtual Reality Approach	N/A
Not yet recruiting	`NCT06300307` - Study of ATX-01 in Participants With DM1	Phase 1/Phase 2
Completed	`NCT02729597` - Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study	N/A
Recruiting	`NCT06138743` - Study of ARO-DM1 in Subjects With Type 1 Myotonic Dystrophy	Phase 1
Not yet recruiting	`NCT05532813` - Evaluation of the Efficacy and Safety of Metformin in the Myotonic Dystrophy Type 1 (Steinert's Disease)	Phase 3
Active, not recruiting	`NCT04886518` - Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1	Phase 2
Not yet recruiting	`NCT05865483` - Profile of Dysphagia in Myotonic Dystrophy Type 1 (DM1)
Completed	`NCT05036447` - Myotonic Dystrophy Type 1 and Resistance Exercise	N/A
Recruiting	`NCT03424460` - Venous Thromboembolism in Myotonic Dystrophy Type 1	N/A
Completed	`NCT04001920` - Effects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1	N/A
Completed	`NCT02858908` - Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy	Phase 2